Boston Scientific
BSX
BSX
668 hedge funds and large institutions have $41.7B invested in Boston Scientific in 2018 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 223 increasing their positions, 225 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
668
Holders Change
+38
Holders Change %
+6.03%
% of All Funds
15.31%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.34%
New
96
Increased
223
Reduced
225
Closed
56
Calls
$235M
Puts
$136M
Net Calls
+$98.2M
Net Calls Change
+$86.1M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$5.12B |
| 2 |
Citadel Advisors
Miami,
Florida
|
$224M |
| 3 |
Morgan Stanley
New York
|
$246M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$189M |
| 5 |
Invesco
Atlanta,
Georgia
|
$271M |
Top Sellers
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
$187M |
| 2 |
Two Sigma Advisers
New York
|
$89.2M |
| 3 |
Millennium Management
New York
|
$240M |
| 4 |
D.E. Shaw & Co
New York
|
$29.6M |
| 5 |
MWNA
Marshall Wace North America
New York
|
$293M |
